Log in to save to my catalogue

Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6eea8a93454d4c5da18bc814dc412708

Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

About this item

Full title

Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2024-11, Vol.26 (1), p.190-24, Article 190

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by increased levels of inflammation that primarily manifests in the joints. Macrophages act as key drivers for the progression of RA, contributing to the perpetuation of chronic inflammation and dysregulation of pro-inflammatory cytokines such as interleukin 1 (IL-1). The goal...

Alternative Titles

Full title

Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6eea8a93454d4c5da18bc814dc412708

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6eea8a93454d4c5da18bc814dc412708

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-024-03425-3

How to access this item